Professional Documents
Culture Documents
Dr.T.V.Rao MD
Dr.T.V.Rao MD
Arthropod-borne Viruses
Arboviruses belong to three families 1. Togaviruses e.g. EEE, WEE, and VEE 2. Bunyaviruses e.g. Sandfly Fever, Rift Valley Fever, Crimean-Congo Haemorrhagic Fever
DENGUE FEVER
Dr.T.V.Rao MD
Arboviruses
The Arbovirus are also called as Arthropod borne viruses, represent an ecological grounding of viruses with complex transmission cycles involving Arthropods These viruses have diverse physical and chemical properties and are classified in several virus families. Dengue infection is caused by Arbovirus
Dr.T.V.Rao MD
Man-Arthropod-Man Cycle
Dr.T.V.Rao MD
History - Dengue
This disease was first described 1780, and the virus was isolated by Sabin 1944. Dengue virus infection is the most common arthropod-borne disease worldwide with an increasing incidence in the tropical regions of Asia, Africa, and Central and South America.
Dr.T.V.Rao MD 6
Dengue
Dengue is the biggest Arbovirus problem in the world today with over 2 million cases per year. Dengue is found in SE Asia, Africa and the Caribbean and S America.
Current Trends
In the 1980s, DHF began a second expansion into Asia when Sri Lanka, India, and the Maldives Islands had their first major DHF epidemics; Pakistan first reported an epidemic of dengue fever in 1994..
Dr.T.V.Rao MD 9
Distribution of Dengue
Dr.T.V.Rao MD
10
11
Dr.T.V.Rao MD
12
Pathogenesis
Presence of existing Dengue antibody, associated with fresh viral infection with new serotype complexes and forms within few days of the second dengue infection. Non neutralizing enhancing antibodies promote infection of higher number of Mononuclear cells.
Dr.T.V.Rao MD 17
Immunology Dengue
Four serotypes exist distinguished by Molecular basis and Nt tests Infection confers life long immunity But cross protection between serotypes is of short duration. Reinfection with different serotype after primary attack is more dangerous causes Dengue hemorrhagic fever.
Dr.T.V.Rao MD 18
Clinical Manifestations
Any or few of the following events can occur. Fever, Severe head ache Muscle and joint pains Nausea, vomiting, Eye pain
Dr.T.V.Rao MD 19
On majority of the occasions a self limited condition, Subside on its own Death is a rare event.
Dr.T.V.Rao MD 20
Dr.T.V.Rao MD
21
Dr.T.V.Rao MD
22
Dr.T.V.Rao MD
26
Dr.T.V.Rao MD
29
Diagnosis
In resource rich establishments
1 Reverse transcriptase polymerase chain reaction methods help rapid identification 2 Isolation of virus is difficult 3 The current favored approach is inoculation of mosquito cell line with patient serum coupled with nucleic acid assay to identify a recovered virus.
Dr.T.V.Rao MD 31
Dengue Serology
The serology is limited with cross reactivity of IgG antibodies to heterologous Flavivirus antigens Most commonly used methods are Viral protein specific capture IgM or IgG by ELISA IgM antibodies develop within few days of illness
Neutralizing anti Haemagglutination inhibiting antibodies appear within a week after onset of Dengue fever Dr.T.V.Rao MD
32
Analysis of paired acute and convalescent sera to show significant rise in antibody titer is the most reliable evidence of an active dengue infection.
Dr.T.V.Rao MD 33
Treatment
No Anti viral therapy available Symptomatic management in Majority of cases Dengue Hemorrhagic fever to be treated with suitable fluid replacement No Vaccine available, difficult in view of four serotypes.
Dr.T.V.Rao MD
35
Control of Dengue
Control of Mosquito breeding places. Anti mosquito measures Use of Insecticides. Screened windows and doors can reduce exposure to vectors.
Dr.T.V.Rao MD 36
Epidemiology - Dengue
Dengue virus are distributed world wide in tropical regions. Where the Aedes vectors exist, are endemic areas Changing and increasing incidences are associated with rapid urban population growth, over crowding and lax mosquito control measures
Dr.T.V.Rao MD 37
Dr.T.V.Rao MD
38
Potential for aerosol dissemination, with human infection via respiratory route (except dengue) Target organ: vascular bed Mortality 0.5 - 90%, depending on agent
Dr.T.V.Rao MD 40
Arenaviruses
Bunyaviruses
Dr.T.V.Rao MD
41
Category C agents
Hantaviruses Tick-borne hemorrhagic fever viruses Yellow fever
Dr.T.V.Rao MD 42
Rift Valley fever has potential to infect domestic animals following a biological attack
Dr.T.V.Rao MD 43
Dr.T.V.Rao MD
44
Dr.T.V.Rao MD
45
VHF Surveillance:
Clinical Identification of Suspected Cases
Clinical criteria:
Temperature 101 F(38.3 C) for <3 weeks Severe illness and no predisposing factors for hemorrhagic manifestations 2 or more of the following:
Hemorrhagic or purple rash Epistaxis Hematemesis Hemoptysis Blood in stools Other hemorrhagic symptoms No established alternative diagnosis
Dr.T.V.Rao MD
46
Dr.T.V.Rao MD
47
Dr.T.V.Rao MD
48
If unavailable, pretreat serum w/Triton X-100 Lab samples double-bagged & hand-carried to lab
Dr.T.V.Rao MD
52
Pathogenesis.
Enters through the bite of Insect vector, Multiply in RES. Target the organ CNS Encephalitis, Liver Yellow fever, Capillary endothelium in Hemorrhagic fevers.
Dr.T.V.Rao MD
53
Hanta Viruses,
Human disease Hemorrhagic fever with renal syndrome Hanta virus pulmonary syndrome. Spread by inhalation of Aerosols of Rodent Excreta, Renal Involvement and failure Lead to Hemorrhagic shock, Korea Spread by Rats carried in ships,
Dr.T.V.Rao MD 55
Dr.T.V.Rao MD
56
Laboratory Diagnosis
Filoviruses. Marburg
Marburg 1967 African Green Monkey, Bat Rodent Host Human. East Africa Monkey Humans.
Dr.T.V.Rao MD
59
Filoviruses - Ebola
Incubation 2-21 days Carries 80% mortality. Barrier Nursing Most essential. ELISA test Culturing Hazardous. RT-PCR Transporting and carrying Primates is Hazardous
Dr.T.V.Rao MD 60
Sudan Gabon
1976, 1979, 2004
Uganda
2000
1976, 1995
0 2,000 kilometers
Dr.T.V.Rao MD
4,000
South Africa
1996*
61
Dr.T.V.Rao MD
62
67
CCHF: Pathogenesis
Viremia present throughout disease
IFA becomes positive in patients destined to survive days 4-6, often simultaneously with viremia
Recovery may be due to CMI or neutralizing antibodies
Dr.T.V.Rao MD
68
PREVENTION OF CCHF
DEET repellents for skin Permethrin repellents for clothing
(0.5% permethrin should be applied to clothing ONLY)
Check for and remove ticks at least twice daily. If a tick attaches, do not injure or rupture the tick.
Remove ticks by grasping mouthparts at the skin surface using forceps and apply steady traction.
Dr.T.V.Rao MD 70
71
Dr.T.V.Rao MD
72
Careful hydration
Pressors, cardiotonic drugs Support of coagulation system
Dr.T.V.Rao MD 74
Ribavirin
Guanosine nucleoside analog:
blocks viral replication by inhibiting IMP dehydrogenase
Ribavirin: toxicities
Teratogenic Extravascular hemolysis Bone marrow suppression
Rigors with abrupt iv administration Reversible hyperbilirubinemia, hyperuricemia with oral administration Pruritus, nausea, depression, cough
Dr.T.V.Rao MD 76
Programme Created By Dr.T.V.Rao MD for Medical and Paramedical Students in Developing World
Email doctortvrao@gmail.com
Dr.T.V.Rao MD
77